Q3 2017 Holdings
Filed 2017-11-13 | 21 holdings | $64.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | COM | 04351P101 | $47.1M | 1,299,052 | 73.6% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $16.6M | 3,165,457 | 25.9% |
| AveXis Inc | COM | 05366U100 | $100.2K | 1,035,657 | 0.2% |
| Biohaven Pharmaceuticals(BHVN) | COM | G11196105 | $60.8K | 1,664,300 | 0.1% |
| Zogenix | COM | 98978L204 | $31.8K | 907,057 | 0.0% |
| DBV Technologies | COM | F2927N109 | $22.4K | 373,617 | 0.0% |
| Argenx(ARGX) | COM | 04016X101 | $14.5K | 647,015 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $13.7K | 1,279,267 | 0.0% |
| Obseva SA | COM | H5861P103 | $11.4K | 1,401,343 | 0.0% |
| MyoKardia | COM | 62857M105 | $11.4K | 265,000 | 0.0% |
| Ra Pharmaceuticals | COM | 74933V108 | $11.2K | 769,771 | 0.0% |
| AnaptysBio(ANAB) | COM | 032724106 | $5.9K | 167,550 | 0.0% |
| Bellerophon Therapeutics(BLPHEUR) | COM | 078771102 | $4.7K | 4,149,378 | 0.0% |
| Akari Therapeutics Plc | COM | 00972G108 | $2.6K | 426,297 | 0.0% |
| Lipocine Inc | COM | 53630X104 | $1.5K | 386,928 | 0.0% |
| Kalvista Pharmaceuticals(KALV) | COM | 483497103 | $1.5K | 221,651 | 0.0% |
| Madrigal Pharmaceuticals(MDGL) | COM | 558868105 | $1.3K | 30,000 | 0.0% |
| Arca biopharma Inc | COM | 00211Y100 | $1.2K | 1,078,932 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $1.0K | 280,000 | 0.0% |
| Ocera Therapeutics | COM | 67552A108 | $544 | 477,269 | 0.0% |
| Axovant Sciences Ltd | COM | G0750W104 | $524 | 76,162 | 0.0% |